Home/Filings/4/0001854270-23-000018
4//SEC Filing

Rajangam Kanya 4

Accession 0001854270-23-000018

CIK 0001854270other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:20 PM ET

Size

5.6 KB

Accession

0001854270-23-000018

Insider Transaction Report

Form 4
Period: 2023-02-01
Rajangam Kanya
Pres. & Chief Med. & Dev. Off.
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-01+130,000130,000 total
    Exercise: $1.81Exp: 2033-01-31Common Stock (130,000 underlying)
Footnotes (1)
  • [F1]The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2023, subject to the reporting person's continued service through the applicable vesting date.

Issuer

Senti Biosciences, Inc.

CIK 0001854270

Entity typeother

Related Parties

1
  • filerCIK 0001816676

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:20 PM ET
Size
5.6 KB